AeriSeal System: Clinical Trials

3 trials of AeriSeal System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 2, Completed 1
Phase 22Completed 1, Terminated 1

Follow AeriSeal System: new trials by email Literature Review of AeriSeal System trials Research Report on AeriSeal System

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
Treatment plus Optimal Medical Therapy, Optimal Medical Therapy - Pulmonary Emphysema
Phase 3TerminatedAeris Therapeutics3002012-06-012013-11-14
A Continuation Study of the AeriSealĀ® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
AeriSeal System - Pulmonary Emphysema, Chronic Obstructive Pulmonary Disease(COPD)
Phase 2 / Phase 3TerminatedAeris Therapeutics182011-03-012013-11-14
AeriSealĀ® System for Lung Volume Reduction in Patients With Advanced Emphysema
AeriSeal System - Pulmonary Emphysema, COPD
Phase 2 / Phase 3CompletedAeris Therapeutics202010-08-012011-10-21

Conditions studied

Emphysema (3)  ·  Lung Diseases (3)  ·  Pulmonary Disease, Chronic Obstructive (3)  ·  Pulmonary Emphysema (3)  ·  Respiratory Tract Diseases (3)  ·  Pathologic Processes (2)  ·  Respiratory Aspiration (2)

Sponsors

Aeris Therapeutics (3)

Countries

Israel (3)  ·  France (1)  ·  Greece (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United States (1)

Results publications

PMID 22374920, PMID 25837041